Mizuho raises Haemonetics stock price target to $85 on plasma demand

Summary

Event (importance: low). Key entities: Mizuho. KB match (other): "The best photos from NASA's first moon mission in ". Affected sectors: healthcare. Primary variables: equity_valuations, investor_sentiment. Causal chain: Mizuho's revised stock price target reflects increasing confidence in Immix Biopharma's cash position, leading to improved investor sentiment and equity valuations.

Market Impact

Key variables: equity valuations in the healthcare sector

Affected sectors: healthcare